INDIANAPOLIS, March 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for agents targeting SMARCA2 (BRM) and multiple KRAS mutations will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April...
Read More Details
Finally We wish PressBee provided you with enough information of ( Lilly announces details of presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting )
Also on site :
- Will Target Open on Memorial Day?
- Christie Brinkley Shares Heartfelt Tribute to Ex-Husband Billy Joel Following Brain Disorder Diagnosis
- Shirtless ‘Penguin’ Star, 48, Shocks Fans With Drastic Body Transformation During Rare Los Angeles Sighting